Development of second primary cancer in Korean breast cancer survivors

被引:24
作者
Jung, Hong Kyu [1 ]
Park, Suyeon [2 ]
Kim, Nam Won [3 ]
Lee, Jong Eun [4 ]
Kim', Zisun [5 ]
Han, Sun Wook [4 ]
Hur, Sung Mo [5 ]
Kim, Sung Young [4 ]
Lim, Cheol Wan [5 ]
Lee, Min Hyuk [2 ,3 ]
Lee, Jihyoun [2 ,3 ]
机构
[1] Seran Gen Hosp, Dept Surg, Seoul, South Korea
[2] Soonchunhyang Univ, Seoul Hosp, Dept Biostat, Seoul, South Korea
[3] Soonchunhyang Univ, Seoul Hosp, Dept Surg, 59 Daesagwan Ro, Seoul 04401, South Korea
[4] Soonchunhyang Univ, Cheonan Hosp, Dept Surg, Cheonan, South Korea
[5] Soonchunhyang Univ, Bucheon Hosp, Dept Surg, Bucheon, South Korea
关键词
Breast neoplasms; Neoplasms; Second primary; Survivors; Early detection of cancer; ENDOMETRIAL CANCER; UNITED-STATES; RISK; METAANALYSIS; TAMOXIFEN; WOMEN; ASSOCIATION;
D O I
10.4174/astr.2017.93.6.287
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose: Breast cancer survivors have slightly increased the risk of second primary cancers. Breast, colon, uterine, and ovarian cancers are common secondary cancers in breast cancer survivors. In this study, we assessed the development of second primary cancers of breast cancer survivors in Korea. Methods: Medical records of patients with breast cancer in 3 tertiary medical institutions were reviewed retrospectively. We evaluated secondary malignancy diagnosed at least 2 months after the breast cancer diagnosis. Based on the International Classification of Disease-9 codes of malignancies, secondary primary breast cancer records were evaluated with person-year adjustment. The standardized incidence ratio (SIR) was assessed using national cancer incidence. Results: A total of 3,444 treatment records were included from 3 medical centers. The cumulative incidence of overall second primary cancers was 2.8% (n = 93).,The SIR was significantly higher in all sites (1.56; 95% confidence interval [CI], 1.26-1.91), endometrial cancer (5.65; 95% CI, 2.06-12.31), biliary tract cancer (3.96; 95% CI, 1.19-8.60), and thyroid cancer (2.29; 95% CI, 1.67-3.08). Conclusion: The incidence of cancer was higher in breast cancer survivors compared to general population. Surveillance of secondary cancer in this group should be recommended individually considering the benefit related to the prognosis of primary breast cancer.
引用
收藏
页码:287 / 292
页数:6
相关论文
共 24 条
  • [1] Risk of second primary cancer among patients with early operable breast cancer registered or randomised in Danish Breast Cancer Cooperative Group (DBCG) protocols of the 77, 82 and 89 programmes during 1977-2001
    Andersson, Michael
    Jensen, Maj-Britt
    Engholm, Gerda
    Storm, Hans Henrik
    [J]. ACTA ONCOLOGICA, 2008, 47 (04) : 755 - 764
  • [2] [Anonymous], 2014, ANN REP CANC STAT KO
  • [3] Meta-analysis of vascular and neoplastic events associated with tamoxifen
    Braithwaite, RS
    Chlebowski, RT
    Lau, J
    George, S
    Hess, R
    Col, NF
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 (11) : 937 - 947
  • [4] Ovulation induction and cancer risk
    Brinton, LA
    Moghissi, KS
    Scoccia, B
    Westhoff, CL
    Lamb, EJ
    [J]. FERTILITY AND STERILITY, 2005, 83 (02) : 261 - 274
  • [5] Risk of second non-hematological malignancies among 376,825 breast cancer survivors
    Brown, Linda Morris
    Chen, Bingshu E.
    Pfeiffer, Ruth M.
    Schairer, Catherine
    Hall, Per
    Storm, Hans
    Pukkala, Eero
    Langmark, Froydis
    Kaijser, Magnus
    Andersson, Michael
    Joensuu, Heikki
    Fossa, Sophie D.
    Travis, Lois B.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 (03) : 439 - 451
  • [6] Aromatase inhibitors, tamoxifen, and endometrial cancer in breast cancer survivors
    Chlebowski, Rowan T.
    Schottinger, Joanne E.
    Shi, Jiaxiao
    Chung, Joanie
    Haque, Reina
    [J]. CANCER, 2015, 121 (13) : 2147 - 2155
  • [7] Curtis R. E., 2006, NIH PUBL
  • [8] Excess body weight and second primary cancer risk after breast cancer: a systematic review and meta-analysis of prospective studies
    Druesne-Pecollo, Nathalie
    Touvier, Mathilde
    Barrandon, Emilie
    Chan, Doris S. M.
    Norat, Teresa
    Zelek, Laurent
    Hercberg, Serge
    Latino-Martel, Paule
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 135 (03) : 647 - 654
  • [9] ENDOMETRIAL CANCER IN TAMOXIFEN-TREATED BREAST-CANCER PATIENTS - FINDINGS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT (NSABP) B-14
    FISHER, B
    COSTANTINO, JP
    REDMOND, CK
    FISHER, ER
    WICKERHAM, DL
    CRONIN, WM
    BOWMAN, D
    COUTURE, J
    DIMITROV, NV
    EVANS, J
    FARRAR, W
    KAVANAH, M
    LICKLEY, HL
    MARGOLESE, R
    PATERSON, AHG
    ROBIDOUX, A
    SHIBATA, H
    TERZ, J
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (07): : 527 - 537
  • [10] Hormones and breast and endometrial cancers: Preventive strategies and future research
    Hulka, BS
    Brinton, LA
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 1995, 103 : 185 - 189